Vascepa 1 GM capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FNAXR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,854
Award facts
- Contract value 100% obligated
- $2,854.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,854.46 to AmerisourceBergen Drug Corp for VASCEPA 1 GM Capsule 120S on September 18, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen Drug Corp's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp fulfills this order as part of its extensive portfolio of medical product deliveries supporting military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The prime contract, designated SPE2DX, enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and other medical commodities across multiple therapeutic domains. The DLA has indicated plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, allowing AmerisourceBergen Drug Corp to continue serving customers including the Defense Health Agency and U.S. Coast Guard through this flexible contract mechanism.
Quick answers
Who was awarded contract SPE2DB25FNAXR?
SPE2DB25FNAXR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FNAXR worth?
The government has obligated $2,854 on SPE2DB25FNAXR.
Is contract SPE2DB25FNAXR an order under another contract?
Yes. SPE2DB25FNAXR is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FNAXR competed?
The extent of competition for SPE2DB25FNAXR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award